Data search
Results for MligTC455_33202
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_33202 | 92 | 1.92 | Mlig455_016989, Mlig455_021240, Mlig455_062989 | Neo: - Age: - |
FCN2 | Mlig455_016989 {REF} {Length: 3214} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=143.0]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=135, Expect=2e-37]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=130, Expect=5e-34]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=128, Expect=1e-33]; ENSMUSG00000026938, Fcna, ficolin A, [Score=126, Expect=1e-33]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=125, Expect=2e-32]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=124, Expect=5e-32]; ENSMUSG00000026835, Fcnb, ficolin B, [Score=122, Expect=2e-32]} {Dmel: FBgn0034160, CG5550, [RH, Score=136, Expect=2e-38]} {Celegans: WBGene00017013, ensh-1, [RH, Score=66.2, Expect=4e-12]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=46.2, Expect=1e-06]} {RNA1509_26827} {RNA1310_48119} {RNA815_52558} Mlig455_021240 {REF} {Length: 2191} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=112.3]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=104, Expect=6e-26]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=99.0, Expect=3e-23]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=98.2, Expect=4e-23]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=97.4, Expect=7e-23]; ENSMUSG00000026938, Fcna, ficolin A, [Score=97.1, Expect=3e-23]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=95.5, Expect=3e-22]; ENSMUSG00000042436, Mfap4, microfibrillar-associated protein 4, [Score=94.4, Expect=1e-22]; ENSMUSG00000026835, Fcnb, ficolin B, [Score=93.6, Expect=4e-22]} {Dmel: FBgn0034160, CG5550, [Score=104, Expect=9e-27]} {Celegans: WBGene00017013, ensh-1, [Score=52.8, Expect=8e-08]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=46.6, Expect=8e-07]} {RNA1509_26827} {RNA1310_48119} {RNA815_52558} Mlig455_062989 {REF} {Length: 1896} {NoTransDecoderORF} {RNA1509_54825} {RNA1310_118627, RNA1509_54825} {RNA1509_54825, RNA815_47526} |
Cumulative graph for MligTC455_33202
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -0.546 | 1.792 | 0.99965 | 1.00000 | |
| RegionR2 | 2.276 | 1.792 | 0.09191 | 0.37196 | |
| RegionR3 | 0.346 | 1.792 | 0.38768 | 0.91879 | |
| RegionR4 | 1.522 | 1.792 | 0.25020 | 0.54958 | |
| RegionR5 | -3.772 | 1.792 | 0.99988 | 1.00000 | |
| RegionR6 | -3.982 | 1.792 | 0.99963 | 1.00000 | |
| RegionR7 | 0.338 | 1.792 | 0.48583 | 1.00000 | |
| RegionR8 | 3.818 | 1.792 | 0.00388 | 0.10895 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -0.455 | 1.792 | 0.99999 | 1.00000 | |
| RegenerationR2 | 1.019 | 1.792 | 0.33260 | 0.76899 | |
| RegenerationR3 | 2.129 | 1.792 | 0.14578 | 0.57303 | |
| RegenerationR4 | 1.267 | 1.792 | 0.41871 | 0.82506 | |
| RegenerationR5 | 4.2 | 1.792 | 0.01098 | 0.18494 | |
| RegenerationR6 | 4.1 | 1.792 | 0.07138 | 0.33376 | |
| RegenerationBL | -2.236 | 1.792 | 0.99958 | 1.00000 | |
| RegenerationTP | -0.61 | 1.792 | 0.73029 | 1.00000 |
Genes with expression patterns similar to MligTC455_33202
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_33202 | 92 | 1.92 | Mlig455_016989, Mlig455_021240, Mlig455_062989 | Neo: - Age: - |
FCN2 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_016989 {REF} {Length: 3214} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=143.0]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=135, Expect=2e-37]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=130, Expect=5e-34]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=128, Expect=1e-33]; ENSMUSG00000026938, Fcna, ficolin A, [Score=126, Expect=1e-33]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=125, Expect=2e-32]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=124, Expect=5e-32]; ENSMUSG00000026835, Fcnb, ficolin B, [Score=122, Expect=2e-32]} {Dmel: FBgn0034160, CG5550, [RH, Score=136, Expect=2e-38]} {Celegans: WBGene00017013, ensh-1, [RH, Score=66.2, Expect=4e-12]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=46.2, Expect=1e-06]} {RNA1509_26827} {RNA1310_48119} {RNA815_52558} Mlig455_021240 {REF} {Length: 2191} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=112.3]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=104, Expect=6e-26]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=99.0, Expect=3e-23]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=98.2, Expect=4e-23]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=97.4, Expect=7e-23]; ENSMUSG00000026938, Fcna, ficolin A, [Score=97.1, Expect=3e-23]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=95.5, Expect=3e-22]; ENSMUSG00000042436, Mfap4, microfibrillar-associated protein 4, [Score=94.4, Expect=1e-22]; ENSMUSG00000026835, Fcnb, ficolin B, [Score=93.6, Expect=4e-22]} {Dmel: FBgn0034160, CG5550, [Score=104, Expect=9e-27]} {Celegans: WBGene00017013, ensh-1, [Score=52.8, Expect=8e-08]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=46.6, Expect=8e-07]} {RNA1509_26827} {RNA1310_48119} {RNA815_52558} Mlig455_062989 {REF} {Length: 1896} {NoTransDecoderORF} {RNA1509_54825} {RNA1310_118627, RNA1509_54825} {RNA1509_54825, RNA815_47526} |
| 2. | MligTC455_38810 | 655 | 13.64 | Mlig455_021157, Mlig455_021360, Mlig455_021587 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.289 Region-enriched R2: 2.927/0.00001 |
NELL2 | 3.273 | - | 0.704 | 0.897 | 0.713 | - | 0.959 | Mlig455_021157 {REF} {Length: 4103} {Smed: dd_Smed_v6_13075_0_2, dd_Smed_v6_13075_0_2, [Score=57.8, Expect=4e-08]} {RNA1509_22586} {RNA1310_1033} {RNA815_17785} Mlig455_021360 {REF} {Length: 7457} {Pfam: Calcium-binding EGF domain [PF07645.17, score=34.6]; EGF domain [PF12947.9, score=33.5]; TNFR/NGFR cysteine-rich region [PF00020.20, score=27.7]; Complement Clr-like EGF-like [PF12662.9, score=20.4]} {Human: ENSG00000184613, NELL2, neural EGFL like 2, [Score=63.5, Expect=4e-09]; ENSG00000168743, NPNT, nephronectin, [Score=62.4, Expect=6e-09]; ENSG00000165973, NELL1, neural EGFL like 1, [Score=60.8, Expect=3e-08]} {Mouse: ENSMUSG00000000402, Egfl6, EGF-like-domain, multiple 6, [Score=63.2, Expect=3e-09]; ENSMUSG00000022454, Nell2, NEL-like 2, [Score=63.2, Expect=3e-09]; ENSMUSG00000002885, Adgre5, adhesion G protein-coupled receptor E5, [Score=62.0, Expect=6e-09]; ENSMUSG00000040998, Npnt, nephronectin, [Score=62.0, Expect=5e-09]} {Dmel: FBgn0035798, frac, faulty attraction, [Score=54.7, Expect=1e-06]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [Score=68.9, Expect=4e-11]} {Smed: dd_Smed_v6_13075_0_1, dd_Smed_v6_13075_0_1, [RH, Score=146, Expect=9e-35]} {RNA1509_49441} {RNA1310_699, RNA1509_49441} {RNA1509_49441, RNA815_6324} Mlig455_021587 {REF} {Length: 2362} {RNA1509_22586} {RNA1310_1033} {RNA815_22832} |
| 3. | MligTC455_23599 | 300 | 6.25 | Mlig455_025579 | Neo: - Age: Up-Down-Down Region-enriched R8: 3.645/0.00082 |
FBN2 | 2.804 | 0.952 | - | - | 0.942 | - | 0.910 | Mlig455_025579 {REF} {Length: 10696} {Pfam: Calcium-binding EGF domain [PF07645.17, score=312.2]; Complement Clr-like EGF-like [PF12662.9, score=241.1]; Coagulation Factor Xa inhibitory site [PF14670.8, score=125.1]; EGF domain [PF12947.9, score=95.9]; EGF-like domain [PF00008.29, score=59.7]; Human growth factor-like EGF [PF12661.9, score=47.9]; Thrombospondin type 1 domain [PF00090.21, score=28.9]; MSP1 EGF domain 1 [PF12946.9, score=21.3]} {Human: ENSG00000138829, FBN2, fibrillin 2, [Score=250, Expect=2e-65]; ENSG00000166147, FBN1, fibrillin 1, [Score=248, Expect=1e-64]; ENSG00000142449, FBN3, fibrillin 3, [Score=243, Expect=3e-63]} {Mouse: ENSMUSG00000024598, Fbn2, fibrillin 2, [Score=253, Expect=1e-66]; ENSMUSG00000027204, Fbn1, fibrillin 1, [Score=251, Expect=5e-66]} {Dmel: FBgn0035798, frac, faulty attraction, [RH, Score=238, Expect=3e-62]} {Celegans: WBGene00001403, fbl-1, Fibulin-1, [Score=192, Expect=3e-50]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=294, Expect=3e-79]} {RNA1509_13106} {RNA1310_487} {RNA815_5734} |
| 4. | MligTC455_23598 | 236 | 4.92 | Mlig455_025573 | Neo: - Age: Up-Down-Down Region-enriched R8: 3.347/0.00904 Regeneration-downregulated BL: -7.152 Regeneration-depleted BL: -7.152 |
FBN1 | 2.793 | 0.952 | - | - | 0.933 | - | 0.908 | Mlig455_025573 {REF} {Length: 8300} {Pfam: Calcium-binding EGF domain [PF07645.17, score=308.8]; Complement Clr-like EGF-like [PF12662.9, score=240.6]; Coagulation Factor Xa inhibitory site [PF14670.8, score=137.8]; EGF domain [PF12947.9, score=103.1]; EGF-like domain [PF00008.29, score=67.3]; Human growth factor-like EGF [PF12661.9, score=42.0]; Thrombospondin type 1 domain [PF00090.21, score=27.9]; MSP1 EGF domain 1 [PF12946.9, score=23.5]} {Human: ENSG00000166147, FBN1, fibrillin 1, [Score=274, Expect=5e-73]; ENSG00000138829, FBN2, fibrillin 2, [Score=265, Expect=2e-70]; ENSG00000142449, FBN3, fibrillin 3, [Score=263, Expect=1e-69]} {Mouse: ENSMUSG00000027204, Fbn1, fibrillin 1, [Score=291, Expect=2e-78]} {Dmel: FBgn0035798, frac, faulty attraction, [RH, Score=235, Expect=8e-62]} {Celegans: WBGene00001403, fbl-1, Fibulin-1, [Score=165, Expect=2e-41]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=292, Expect=8e-79]} {RNA1509_13106} {RNA1310_487} {RNA815_5734} |
| 5. | MligTC455_50837 | 14 | 0.29 | Mlig455_013450 | Neo: - Age: - |
PLSCR5 | 2.738 | 0.837 | - | 0.961 | - | 0.940 | - | Mlig455_013450 {REF} {Length: 1455} {Pfam: Scramblase [PF03803.17, score=121.2]} {Human: ENSG00000231213, PLSCR5, phospholipid scramblase family member 5, [Score=102, Expect=2e-24]; ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=97.8, Expect=3e-22]} {Mouse: ENSMUSG00000095654, Plscr5, phospholipid scramblase family, member 5, [Score=102, Expect=1e-24]; ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=97.8, Expect=2e-22]} {Dmel: FBgn0035390, scramb2, scramblase 2, [Score=87.8, Expect=2e-19]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=102, Expect=9e-25]} {Smed: dd_Smed_v6_4312_0_2, dd_Smed_v6_4312_0_2, [Score=92.4, Expect=1e-21]} {RNA1310_119369} |
| 6. | MligTC455_50643 | 38 | 0.8 | Mlig455_007952, Mlig455_008053 | Neo: - Age: - |
VSX1 | 2.644 | - | - | 0.914 | 0.958 | - | 0.772 | Mlig455_007952 {REF} {Length: 1358} {Pfam: Homeodomain [PF00046.31, score=79.6]} {Human: ENSG00000100987, VSX1, visual system homeobox 1, [RH, Score=197, Expect=4e-60]; ENSG00000119614, VSX2, visual system homeobox 2, [RH, Score=196, Expect=2e-59]} {Mouse: ENSMUSG00000021239, Vsx2, visual system homeobox 2, [RH, Score=196, Expect=6e-60]; ENSMUSG00000033080, Vsx1, visual system homeobox 1, [RH, Score=195, Expect=2e-59]} {Dmel: FBgn0263512, Vsx2, Visual system homeobox 2, [RH, Score=204, Expect=3e-60]} {Celegans: WBGene00000435, ceh-10, Homeobox protein ceh-10, [RH, Score=204, Expect=2e-63]} {Smed: dd_Smed_v6_19286_0_1, dd_Smed_v6_19286_0_1, [RH, Score=211, Expect=2e-66]} {RNA1310_76393} {RNA815_51313} Mlig455_008053 {REF} {Length: 2271} {RNA1310_76393} {RNA815_51313} |
| 7. | MligTC455_51275 | 335 | 6.98 | Mlig455_045339 | Neo: - Age: logFC(26M/2M)=-0.374 |
GRM3 | 2.644 | 0.852 | - | - | 0.837 | - | 0.955 | Mlig455_045339 {REF} {Length: 4374} {Pfam: Receptor family ligand binding region [PF01094.30, score=112.7]} {Human: ENSG00000198822, GRM3, glutamate metabotropic receptor 3, [Score=78.2, Expect=7e-14]; ENSG00000164082, GRM2, glutamate metabotropic receptor 2, [Score=76.6, Expect=2e-13]} {Mouse: ENSMUSG00000003974, Grm3, glutamate receptor, metabotropic 3, [Score=75.5, Expect=3e-13]; ENSMUSG00000023192, Grm2, glutamate receptor, metabotropic 2, [Score=73.6, Expect=1e-12]} {Dmel: FBgn0050361, mtt, mangetout, [Score=84.0, Expect=6e-16]} {Celegans: WBGene00021152, mgl-3, Metabotropic GLutamate receptor family, [Score=59.3, Expect=2e-08]} {Smed: dd_Smed_v6_15419_0_1, dd_Smed_v6_15419_0_1, [Score=62.0, Expect=2e-09]} {RNA1509_29529} {RNA1310_2368.1, RNA1509_29529} {RNA1509_29529, RNA815_7926} |
| 8. | MligTC455_48520 | 46 | 0.96 | Mlig455_004433 | Neo: - Age: - |
2.64 | - | 0.769 | 0.958 | - | - | 0.913 | Mlig455_004433 {REF} {Length: 701} {RNA1310_56623} {RNA815_27009} | |
| 9. | MligTC455_20238 | 111 | 2.32 | Mlig455_042456 | Neo: - Age: logFC(26M/2M)=0.413 |
2.624 | - | - | - | 0.784 | 0.890 | 0.950 | Mlig455_042456 {REF} {Length: 3232} {RNA1509_32804} {RNA1310_15777, RNA1509_32804} {RNA1509_32804, RNA815_23756} | |
| 10. | MligTC455_17804 | 27 | 0.56 | Mlig455_069447 | Neo: - Age: - |
2.593 | - | 0.770 | - | 0.958 | - | 0.865 | Mlig455_069447 {REF} {Length: 955} {RNA1310_40722} {RNA815_46396} | |
| 11. | MligTC455_29049 | 441 | 9.18 | Mlig455_042244 | Neo: - Age: - Region-enriched R2: 4.677/0.00000 |
RASGRF1 | 2.569 | - | 0.776 | 0.824 | - | - | 0.969 | Mlig455_042244 {REF} {Length: 6465} {Pfam: RasGEF domain [PF00617.21, score=193.2]; RhoGEF domain [PF00621.22, score=119.3]; PH domain [PF00169.31, score=86.7]; RasGEF N-terminal motif [PF00618.22, score=68.4]; Pleckstrin homology domain [PF15413.8, score=22.6]} {Human: ENSG00000058335, RASGRF1, Ras protein specific guanine nucleotide releasing factor 1, [RH, Score=763, Expect=0.0]; ENSG00000113319, RASGRF2, Ras protein specific guanine nucleotide releasing factor 2, [RH, Score=739, Expect=0.0]} {Mouse: ENSMUSG00000032356, Rasgrf1, RAS protein-specific guanine nucleotide-releasing factor 1, [RH, Score=763, Expect=0.0]} {Dmel: FBgn0001965, Sos, Son of sevenless, [Score=164, Expect=3e-40]} {Celegans: WBGene00004947, sos-1, Son of sevenless homolog, [Score=118, Expect=3e-26]} {Smed: dd_Smed_v6_18313_0_2, dd_Smed_v6_18313_0_2, [RH, Score=1137, Expect=0.0]} {RNA1509_15697} {RNA1310_2543.1} {RNA815_8228.1} |
| 12. | MligTC455_38324 | 621 | 12.93 | Mlig455_061532 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.278 Region-enriched R8: 2.153/0.00059 Regeneration-downregulated BL: -3.944 Regeneration-depleted BL: -3.944 |
NEFH | 2.559 | 0.964 | - | - | - | 0.731 | 0.864 | Mlig455_061532 {REF} {Length: 6211} {Pfam: Tau and MAP protein, tubulin-binding repeat [PF00418.21, score=79.2]} {Human: ENSG00000100285, NEFH, neurofilament heavy, [Score=77.0, Expect=2e-13]} {Mouse: ENSMUSG00000059897, Zfp930, zinc finger protein 930, [Score=72.0, Expect=2e-12]} {Dmel: FBgn0266579, tau, [Score=85.5, Expect=1e-17]} {Celegans: WBGene00004212, ptl-1, Microtubule-associated protein, [Score=81.6, Expect=1e-15]} {Smed: dd_Smed_v6_33588_0_1, dd_Smed_v6_33588_0_1, [Score=64.3, Expect=5e-12]} {RNA1509_27273} {RNA1310_5091} {RNA815_5806} |
| 13. | MligTC455_21755 | 70 | 1.47 | Mlig455_021213 | Neo: - Age: - |
2.55 | - | - | 0.775 | 0.954 | - | 0.821 | Mlig455_021213 {REF} {Length: 4215} {Pfam: F5/8 type C domain [PF00754.27, score=55.5]} {RNA1509_2515} {RNA1310_33166} {RNA815_14716} | |
| 14. | MligTC455_09688 | 16 | 0.32 | Mlig455_020078 | Neo: - Age: - Region-enriched R5: 3.740/0.03280 |
2.536 | - | - | 0.774 | 0.955 | - | 0.807 | Mlig455_020078 {REF} {Length: 803} {Pfam: WSC domain [PF01822.21, score=60.8]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=56.6, Expect=2e-09]} {RNA1509_53783} {RNA1310_40622} {RNA815_30345} | |
| 15. | MligTC455_40610 | 165 | 3.43 | Mlig455_064484 | Neo: - Age: - Region-enriched R2: 5.617/0.00105 |
2.525 | - | - | 0.745 | 0.957 | - | 0.823 | Mlig455_064484 {REF} {Length: 2931} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=24.9]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=154, Expect=2e-40]} {RNA1509_26568} {RNA1310_9342.1, RNA1509_26568} {RNA1509_26568, RNA815_7018} | |
| 16. | MligTC455_40687 | 28 | 0.58 | Mlig455_040563, Mlig455_062078 | Neo: - Age: - |
PDE1C | 2.515 | - | - | 0.957 | - | 0.747 | 0.811 | Mlig455_040563 {REF} {Length: 1798} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.0]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=362, Expect=2e-117]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=358, Expect=2e-117]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=362, Expect=5e-118]; ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=362, Expect=7e-120]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=346, Expect=4e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_21546_0_1, dd_Smed_v6_21546_0_1, [Score=396, Expect=7e-133]} {RNA1310_80402} Mlig455_062078 {REF} {Length: 1807} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.6]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.1]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=356, Expect=3e-115]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=355, Expect=5e-116]} {Mouse: ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=359, Expect=1e-118]; ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=356, Expect=8e-116]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=347, Expect=2e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_26758_0_1, dd_Smed_v6_26758_0_1, [Score=394, Expect=3e-132]} {RNA1509_46211} {RNA1310_80402} {RNA815_55704} |
| 17. | MligTC455_14293 | 27 | 0.55 | Mlig455_005699 | Neo: - Age: - |
2.5 | - | - | - | 0.953 | 0.728 | 0.819 | Mlig455_005699 {REF} {Length: 220} {NoTransDecoderORF} {RNA1509_35414} {RNA1310_4580} | |
| 18. | MligTC455_16246 | 45 | 0.95 | Mlig455_036572 | Neo: - Age: Down-Up-Down |
2.497 | - | - | 0.838 | 0.956 | - | 0.703 | Mlig455_036572 {REF} {Length: 810} {RNA1310_54790} {RNA815_37149} | |
| 19. | MligTC455_41870 | 67 | 1.39 | Mlig455_042417 | Neo: - Age: Up-Down-Up |
ANGPTL1 | 2.466 | - | - | 0.710 | 0.957 | - | 0.799 | Mlig455_042417 {REF} {Length: 1469} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=110.4]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=102, Expect=6e-24]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=99.8, Expect=3e-23]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=104, Expect=6e-25]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=99.4, Expect=4e-23]} {Dmel: FBgn0003326, sca, scabrous, [Score=89.4, Expect=1e-19]} {Celegans: WBGene00017013, ensh-1, [Score=55.1, Expect=2e-08]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=73.6, Expect=1e-14]} {RNA1509_28467} {RNA1310_67810} {RNA815_18070.1} |
| 20. | MligTC455_41471 | 131 | 2.72 | Mlig455_040252, Mlig455_054698 | Neo: - Age: - Region-enriched R2: 3.576/0.00566 |
ANGPTL1 | 2.438 | - | - | - | 0.957 | 0.722 | 0.759 | Mlig455_040252 {REF} {Length: 2778} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.9]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=112, Expect=2e-27]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=107, Expect=2e-25]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=109, Expect=2e-26]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=107, Expect=1e-25]} {Dmel: FBgn0050280, CG30280, [Score=93.6, Expect=5e-22]} {Celegans: WBGene00020516, T15B7.1, [Score=61.6, Expect=1e-10]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=100, Expect=9e-24]} {RNA1509_57196} {RNA1310_23214} {RNA815_19964} Mlig455_054698 {REF} {Length: 3143} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=127.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=108, Expect=4e-26]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=105, Expect=6e-25]; ENSG00000160339, FCN2, ficolin 2, [Score=103, Expect=3e-25]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=105, Expect=3e-25]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=105, Expect=4e-25]; ENSMUSG00000026835, Fcnb, ficolin B, [Score=103, Expect=5e-25]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=103, Expect=2e-24]; ENSMUSG00000042436, Mfap4, microfibrillar-associated protein 4, [Score=102, Expect=4e-25]; ENSMUSG00000015829, Tnr, tenascin R, [Score=102, Expect=7e-24]; ENSMUSG00000026938, Fcna, ficolin A, [Score=102, Expect=9e-25]} {Dmel: FBgn0050280, CG30280, [Score=97.8, Expect=1e-23]} {Celegans: WBGene00020516, T15B7.1, [Score=62.0, Expect=9e-11]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=100, Expect=2e-23]} {RNA1310_23214} {RNA815_19964} |
| 21. | MligTC455_17003 | 32 | 0.66 | Mlig455_011034 | Neo: - |
P2RX2 | 1.873 | - | - | 0.968 | - | - | 0.905 | Mlig455_011034 {REF} {Length: 2894} {Pfam: ATP P2X receptor [PF00864.21, score=288.1]} {Human: ENSG00000187848, P2RX2, purinergic receptor P2X 2, [Score=206, Expect=3e-60]; ENSG00000135124, P2RX4, purinergic receptor P2X 4, [Score=201, Expect=7e-59]} {Mouse: ENSMUSG00000029503, P2rx2, purinergic receptor P2X, ligand-gated ion channel, 2, [Score=202, Expect=8e-59]} {Smed: dd_Smed_v6_10968_0_1, dd_Smed_v6_10968_0_1, [Score=269, Expect=3e-84]} {RNA1509_56054} {RNA1310_31414} {RNA815_43099} |
| 22. | MligTC455_36374 | 58 | 1.2 | Mlig455_016115 | Neo: - Age: - |
1.872 | 0.882 | - | 0.990 | - | - | - | Mlig455_016115 {REF} {Length: 4900} {RNA1509_18263} {RNA1310_1232} {RNA815_347} | |
| 23. | MligTC455_11460 | 16 | 0.32 | Mlig455_007663, Mlig455_020976 | Neo: - Age: - |
GABBR2 | 1.87 | - | - | 0.985 | - | 0.885 | - | Mlig455_007663 {REF} {Length: 3796} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=154.8]; Receptor family ligand binding region [PF01094.30, score=95.6]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=192, Expect=5e-51]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=192, Expect=4e-51]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=184, Expect=2e-48]} {Celegans: WBGene00022675, gbb-2, GABA B receptor subunit; GABAB2 receptor subunit, [Score=186, Expect=1e-49]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=135, Expect=1e-35]} {RNA1509_46835} {RNA1310_28203} {RNA815_41974} Mlig455_020976 {REF} {Length: 3353} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=154.3]; Receptor family ligand binding region [PF01094.30, score=128.3]; Periplasmic binding protein [PF13458.8, score=20.5]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=256, Expect=8e-73]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=250, Expect=7e-71]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=230, Expect=2e-63]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=203, Expect=3e-55]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=133, Expect=7e-35]} {RNA1310_28203} {RNA815_36847} |
| 24. | MligTC455_45051 | 307 | 6.41 | Mlig455_043687, Mlig455_043755 | Neo: - Age: - |
1.87 | - | - | - | 0.920 | - | 0.950 | Mlig455_043687 {REF} {Length: 1460} {RNA1310_17293.1} Mlig455_043755 {REF} {Length: 1366} {TRANSSPLICED} {RNA1310_17293.1} |
|
| 25. | MligTC455_25152 | 168 | 3.51 | Mlig455_040072 | Neo: - Age: - Region-enriched R8: 4.101/0.00210 |
1.869 | 0.919 | - | - | - | 0.950 | - | Mlig455_040072 {REF} {Length: 2067} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=43.4]; TcdA/TcdB catalytic glycosyltransferase domain [PF12919.9, score=22.9]} {Smed: dd_Smed_v6_32358_0_1, dd_Smed_v6_32358_0_1, [Score=57.8, Expect=1e-09]} {RNA1509_20770} {RNA1310_38403} {RNA815_6249} | |
| 26. | MligTC455_43169 | 207 | 4.32 | Mlig455_024672 | Neo: - |
RNF41 | 1.856 | 0.886 | - | - | - | - | 0.970 | Mlig455_024672 {REF} {Length: 2536} {Pfam: Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=42.9]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=35.9]; Ring finger domain [PF13639.8, score=33.6]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=31.6]; RING-type zinc-finger [PF13445.8, score=27.1]; zinc finger of C3HC4-type, RING [PF15227.8, score=25.5]; RING-H2 zinc finger domain [PF12678.9, score=24.6]; TRAF-type zinc finger [PF02176.20, score=24.1]; zinc-RING finger domain [PF14634.8, score=22.6]; Prokaryotic RING finger family 4 [PF14447.8, score=22.0]; Seven in absentia protein family [PF03145.18, score=21.2]; zf-RING of BARD1-type protein [PF14835.8, score=20.1]} {Human: ENSG00000181852, RNF41, ring finger protein 41, [Score=120, Expect=4e-33]} {Mouse: ENSMUSG00000025373, Rnf41, ring finger protein 41, [Score=120, Expect=3e-32]} {Dmel: FBgn0028847, CG9014, [Score=112, Expect=5e-29]} {Smed: dd_Smed_v6_5173_0_1, dd_Smed_v6_5173_0_1, [Score=110, Expect=1e-28]} {RNA1509_36641, RNA1509_42769} {RNA1310_9044.1, RNA1509_36641, RNA1509_42769} {RNA1509_36641, RNA1509_42769, RNA815_14046} |
| 27. | MligTC455_25022 | 32 | 0.66 | Mlig455_006759 | Neo: Int S/G2/M Age: - |
1.841 | - | - | 0.998 | - | - | 0.843 | Mlig455_006759 {REF} {Length: 776} {NoTransDecoderORF} {RNA1509_55535} {RNA1310_62687} {RNA815_43405} | |
| 28. | MligTC455_13039 | 18 | 0.38 | Mlig455_012224, Mlig455_069088 | Neo: - Age: - |
1.833 | - | - | 0.875 | 0.958 | - | - | Mlig455_012224 {REF} {Length: 1882} {Smed: dd_Smed_v6_9937_0_1, dd_Smed_v6_9937_0_1, [Score=177, Expect=1e-50]} {RNA1310_109660} Mlig455_069088 {REF} {Length: 2016} {Smed: dd_Smed_v6_9937_0_1, dd_Smed_v6_9937_0_1, [Score=190, Expect=2e-55]} {RNA1310_109660} |
|
| 29. | MligTC455_14033 | 19 | 0.39 | Mlig455_060854 | Neo: - Age: - |
1.819 | - | - | 0.968 | 0.851 | - | - | Mlig455_060854 {REF} {Length: 2028} {RNA1509_3734} {RNA1310_43722.2} {RNA815_21450.2} | |
| 30. | MligTC455_43170 | 206 | 4.3 | Mlig455_044050 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.754 Region-enriched R8: 2.917/0.04703 |
RNF41 | 1.819 | 0.855 | - | - | - | - | 0.964 | Mlig455_044050 {REF} {Length: 3399} {Pfam: Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=42.9]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=35.9]; Ring finger domain [PF13639.8, score=33.6]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=31.6]; RING-type zinc-finger [PF13445.8, score=27.1]; zinc finger of C3HC4-type, RING [PF15227.8, score=25.5]; RING-H2 zinc finger domain [PF12678.9, score=24.6]; TRAF-type zinc finger [PF02176.20, score=24.1]; zinc-RING finger domain [PF14634.8, score=22.6]; Prokaryotic RING finger family 4 [PF14447.8, score=22.0]; Seven in absentia protein family [PF03145.18, score=21.2]; zf-RING of BARD1-type protein [PF14835.8, score=20.1]} {Human: ENSG00000181852, RNF41, ring finger protein 41, [Score=120, Expect=4e-33]} {Mouse: ENSMUSG00000025373, Rnf41, ring finger protein 41, [Score=120, Expect=3e-32]} {Dmel: FBgn0028847, CG9014, [Score=112, Expect=4e-29]} {Smed: dd_Smed_v6_5173_0_1, dd_Smed_v6_5173_0_1, [Score=110, Expect=1e-28]} {RNA1509_36641, RNA1509_49465} {RNA1310_9044.1, RNA1509_49465} {RNA1509_49465, RNA815_14046} |
| 31. | MligTC455_38813 | 50 | 1.04 | Mlig455_008881 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.104/0.01060 |
THSD7A | 1.818 | - | - | 0.976 | - | 0.842 | - | Mlig455_008881 {REF} {Length: 6770} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=138.6]; Thrombospondin type 1 domain [PF19030.2, score=34.2]; Thrombospondin type 1 domain [PF00090.21, score=26.3]} {Human: ENSG00000005108, THSD7A, thrombospondin type 1 domain containing 7A, [Score=298, Expect=5e-81]} {Mouse: ENSMUSG00000032625, Thsd7a, thrombospondin, type I, domain containing 7A, [Score=303, Expect=8e-83]} {Celegans: WBGene00001650, gon-1, A disintegrin and metalloproteinase with thrombospondin motifs gon-1, [Score=54.7, Expect=8e-07]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=50.4, Expect=1e-05]} {RNA1310_90350} |
| 32. | MligTC455_16781 | 32 | 0.67 | Mlig455_003020, Mlig455_003313 | Neo: - Age: - |
1.817 | - | - | 0.998 | - | - | 0.819 | Mlig455_003020 {REF} {Length: 518} {Pfam: Immunoreceptor tyrosine-based activation motif [PF02189.17, score=26.8]} {RNA1310_57787} {RNA815_49158} Mlig455_003313 {REF} {Length: 905} {Pfam: Immunoreceptor tyrosine-based activation motif [PF02189.17, score=74.4]} {RNA1310_57787} {RNA815_49158} |
|
| 33. | MligTC455_24666 | 48 | 0.99 | Mlig455_029255 | Neo: - Age: Up-Down-Down |
KCNMA1 | 1.816 | - | - | 0.970 | - | 0.846 | - | Mlig455_029255 {REF} {Length: 5026} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=109.2]; Ion transport protein [PF00520.33, score=60.8]; Ion channel [PF07885.18, score=58.9]; Ligand-gated ion channel [PF00060.28, score=21.9]} {Human: ENSG00000156113, KCNMA1, potassium calcium-activated channel subfamily M alpha 1, [Score=947, Expect=0.0]} {Mouse: ENSMUSG00000063142, Kcnma1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1, [Score=946, Expect=0.0]} {Dmel: FBgn0003429, slo, slowpoke, [Score=969, Expect=0.0]} {Celegans: WBGene00004830, slo-1, Calcium-activated potassium channel slo-1, [Score=905, Expect=0.0]} {Smed: dd_Smed_v6_5509_0_1, dd_Smed_v6_5509_0_1, [Score=869, Expect=0.0]} {RNA1509_20450} {RNA1310_2582, RNA1509_20450} {RNA1509_20450, RNA815_1358} |
| 34. | MligTC455_43581 | 177 | 3.68 | Mlig455_042725, Mlig455_042827, Mlig455_063146 | Neo: - Age: Up-Down-Down |
GRIA2 | 1.814 | - | - | - | 0.968 | - | 0.846 | Mlig455_042725 {REF} {Length: 3074} {Pfam: Ligand-gated ion channel [PF00060.28, score=104.7]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.7]; Receptor family ligand binding region [PF01094.30, score=33.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=19.7]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=153, Expect=1e-37]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=149, Expect=2e-36]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=147, Expect=7e-36]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=152, Expect=2e-37]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=148, Expect=3e-36]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=147, Expect=8e-36]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=145, Expect=2e-35]} {Dmel: FBgn0038837, CG3822, [Score=140, Expect=5e-34]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=126, Expect=1e-29]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=253, Expect=2e-76]} {RNA1310_25150} {RNA815_13942} Mlig455_042827 {REF} {Length: 2869} {Pfam: Ligand-gated ion channel [PF00060.28, score=83.9]; Receptor family ligand binding region [PF01094.30, score=49.8]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=20.3]; Iron-containing alcohol dehydrogenase [PF13685.8, score=18.6]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=125, Expect=6e-29]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=122, Expect=5e-28]; ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=121, Expect=7e-28]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=120, Expect=2e-27]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=125, Expect=5e-29]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=122, Expect=4e-28]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=121, Expect=1e-27]; ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=120, Expect=1e-27]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=119, Expect=3e-27]} {Dmel: FBgn0039927, CG11155, [Score=127, Expect=7e-30]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [Score=103, Expect=1e-22]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=217, Expect=2e-63]} {RNA1310_25150} {RNA815_13942} Mlig455_063146 {REF} {Length: 2444} {Pfam: Receptor family ligand binding region [PF01094.30, score=35.8]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=82.4, Expect=1e-16]} {RNA1310_25150} {RNA815_13999} |
| 35. | MligTC455_11493 | 29 | 0.61 | Mlig455_002993 | Neo: - Age: - |
HS3ST5 | 1.802 | - | - | - | 0.950 | - | 0.852 | Mlig455_002993 {REF} {Length: 2472} {Pfam: Sulfotransferase domain [PF00685.29, score=91.7]; Sulfotransferase family [PF13469.8, score=45.8]} {Human: ENSG00000249853, HS3ST5, heparan sulfate-glucosamine 3-sulfotransferase 5, [RH, Score=256, Expect=8e-83]} {Mouse: ENSMUSG00000044499, Hs3st5, heparan sulfate (glucosamine) 3-O-sulfotransferase 5, [RH, Score=258, Expect=1e-83]} {Dmel: FBgn0031005, Hs3st-B, Heparan sulfate 3-O sulfotransferase-B, [Score=205, Expect=7e-63]} {Celegans: WBGene00044303, hst-3.2, Heparan SulphoTransferase, [Score=215, Expect=8e-68]} {Smed: dd_Smed_v6_81402_0_1, dd_Smed_v6_81402_0_1, [Score=123, Expect=6e-34]} {RNA1310_37118} {RNA815_58609} |
| 36. | MligTC455_24615 | 803 | 16.72 | Mlig455_027166 | Neo: - Age: logFC(26M/2M)=-0.507 |
ECT2 | 1.802 | - | - | - | 0.845 | - | 0.957 | Mlig455_027166 {REF} {Length: 2510} {Pfam: RhoGEF domain [PF00621.22, score=124.0]; Winged helix-turn helix [PF13592.8, score=20.5]} {Human: ENSG00000114346, ECT2, epithelial cell transforming 2, [Score=80.9, Expect=2e-15]} {Mouse: ENSMUSG00000020640, Itsn2, intersectin 2, [Score=79.7, Expect=5e-15]; ENSMUSG00000027699, Ect2, ect2 oncogene, [Score=77.0, Expect=3e-14]} {Dmel: FBgn0003041, pbl, pebble, [Score=56.6, Expect=5e-08]} {Celegans: WBGene00002297, ect-2, ECT2 (Mammalian Rho GEF) homolog, [Score=69.7, Expect=3e-12]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [Score=50.1, Expect=3e-06]} {RNA1509_21158} {RNA1310_6370} {RNA815_1845} |
| 37. | MligTC455_29714 | 116 | 2.43 | Mlig455_007409 | Neo: - Age: - |
1.801 | - | - | - | - | 0.843 | 0.958 | Mlig455_007409 {REF} {Length: 1951} {Pfam: Immunoglobulin domain [PF13895.8, score=20.7]} {RNA1310_17050} {RNA815_14516} | |
| 38. | MligTC455_23582 | 290 | 6.04 | Mlig455_043258 | Neo: - Age: logFC(26M/2M)=-1.253 |
CCDC33 | 1.8 | - | - | - | 0.824 | - | 0.976 | Mlig455_043258 {REF} {Length: 3463} {TRANSSPLICED} {Pfam: C2 domain [PF00168.32, score=24.6]; C-terminal membrane-localisation domain of ion-channel, VCN1 [PF16799.7, score=19.4]} {Human: ENSG00000140481, CCDC33, coiled-coil domain containing 33, [RH, Score=94.7, Expect=4e-19]} {Mouse: ENSMUSG00000037716, Ccdc33, coiled-coil domain containing 33, [RH, Score=165, Expect=3e-41]} {Smed: dd_Smed_v6_15844_0_1, dd_Smed_v6_15844_0_1, [RH, Score=195, Expect=4e-51]} {RNA1509_7141} {RNA1310_3740, RNA1509_7141} {RNA1509_7141, RNA815_780.1} |
| 39. | MligTC455_37010 | 127 | 2.64 | Mlig455_012355 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.232/0.00085 |
1.795 | - | - | 0.822 | - | - | 0.973 | Mlig455_012355 {REF} {Length: 7737} {Pfam: HGWP repeat [PF03578.17, score=19.0]} {RNA1509_28298} {RNA1310_3268} {RNA815_628} | |
| 40. | MligTC455_35436 | 244 | 5.09 | Mlig455_066072 | Neo: - Age: - Region-enriched R2: 2.834/0.01983 |
GLRA2 | 1.79 | - | - | 0.840 | - | - | 0.950 | Mlig455_066072 {REF} {Length: 4141} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=147.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=83.1]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=249, Expect=7e-77]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=246, Expect=1e-75]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=241, Expect=9e-74]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=5e-77]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=240, Expect=2e-73]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=237, Expect=2e-72]} {Dmel: FBgn0024963, GluClalpha, [Score=246, Expect=4e-76]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=257, Expect=5e-80]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=448, Expect=7e-155]} {RNA1509_35986} {RNA1310_23400, RNA1509_35986} {RNA1509_35986, RNA815_18122} |
| 41. | MligTC455_06084 | 166 | 3.46 | Mlig455_068382, Mlig455_068392 | Neo: - Age: - |
GRIK3 | 1.789 | - | 0.819 | - | - | - | 0.970 | Mlig455_068382 {REF} {Length: 4172} {Pfam: Ligand-gated ion channel [PF00060.28, score=185.8]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=106.0]; Receptor family ligand binding region [PF01094.30, score=105.1]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=80.9]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=576, Expect=0.0]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=572, Expect=0.0]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=556, Expect=0.0]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=572, Expect=0.0]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=570, Expect=0.0]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=558, Expect=0.0]} {Dmel: FBgn0039927, CG11155, [RH, Score=595, Expect=0.0]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=409, Expect=3e-128]} {Smed: dd_Smed_v6_8816_0_1, dd_Smed_v6_8816_0_1, [Score=486, Expect=8e-156]} {RNA1509_24054} {RNA1310_4432, RNA1509_24054} {RNA1509_24054, RNA815_4162} Mlig455_068392 {REF} {Length: 4194} {Pfam: Ligand-gated ion channel [PF00060.28, score=185.8]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=106.0]; Receptor family ligand binding region [PF01094.30, score=105.0]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=80.9]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=575, Expect=0.0]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=572, Expect=0.0]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=556, Expect=0.0]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=571, Expect=0.0]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=570, Expect=0.0]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=557, Expect=0.0]} {Dmel: FBgn0039927, CG11155, [RH, Score=595, Expect=0.0]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=409, Expect=3e-128]} {Smed: dd_Smed_v6_8816_0_1, dd_Smed_v6_8816_0_1, [Score=486, Expect=9e-156]} {RNA1509_24054, RNA1509_55198} {RNA1310_4432, RNA1509_55198} {RNA1509_55198, RNA815_4162} |
| 42. | MligTC455_39013 | 53 | 1.1 | Mlig455_030082 | Neo: - Age: Up-Down-Down |
PLCB1 | 1.788 | - | - | 0.812 | - | 0.976 | - | Mlig455_030082 {REF} {Length: 5740} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=199.2]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=124.4]; PH domain [PF17787.3, score=120.6]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=33.9]} {Human: ENSG00000182621, PLCB1, phospholipase C beta 1, [RH, Score=826, Expect=0.0]; ENSG00000149782, PLCB3, phospholipase C beta 3, [RH, Score=824, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [RH, Score=826, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [RH, Score=813, Expect=0.0]} {Dmel: FBgn0262738, norpA, no receptor potential A, [Score=670, Expect=0.0]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=680, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_1, dd_Smed_v6_3221_0_1, [Score=724, Expect=0.0]} {RNA1509_47106} {RNA1310_7555, RNA1509_47106} {RNA1509_47106, RNA815_2033} |
| 43. | MligTC455_38402 | 477 | 9.94 | Mlig455_049227 | Neo: - Age: - |
1.788 | - | - | - | 0.824 | - | 0.964 | Mlig455_049227 {REF} {Length: 2450} {TRANSSPLICED} {RNA1509_27392, RNA1509_28215} {RNA1310_19016, RNA1509_27392, RNA1509_28215} {RNA1509_27392, RNA1509_28215, RNA815_11860} | |
| 44. | MligTC455_44612 | 24 | 0.49 | Mlig455_006206, Mlig455_059294 | Neo: - Age: - |
1.788 | - | - | - | 0.969 | - | 0.819 | Mlig455_006206 {REF} {Length: 506} {NoTransDecoderORF} {RNA1509_43593} {RNA1310_56719} {RNA815_29718} Mlig455_059294 {REF} {Length: 1181} {Pfam: PAN domain [PF00024.28, score=19.3]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=66.2, Expect=3e-13]} {RNA1509_35604} {RNA1310_34182} {RNA815_29718} |
|
| 45. | MligTC455_35943 | 122 | 2.55 | Mlig455_062123 | Neo: - |
FEZF2 | 1.785 | - | - | - | 0.950 | - | 0.835 | Mlig455_062123 {REF} {Length: 3163} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=87.7]; Zinc-finger double domain [PF13465.8, score=71.3]; C2H2-type zinc finger [PF13894.8, score=56.0]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=25.4]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=23.1]; C2H2-type zinc finger [PF13912.8, score=21.6]} {Human: ENSG00000153266, FEZF2, FEZ family zinc finger 2, [RH, Score=337, Expect=3e-107]; ENSG00000128610, FEZF1, FEZ family zinc finger 1, [RH, Score=330, Expect=6e-105]} {Mouse: ENSMUSG00000021743, Fezf2, Fez family zinc finger 2, [RH, Score=341, Expect=7e-109]; ENSMUSG00000029697, Fezf1, Fez family zinc finger 1, [RH, Score=330, Expect=1e-104]} {Dmel: FBgn0031375, erm, earmuff, [RH, Score=343, Expect=2e-107]} {Celegans: WBGene00012639, fezf-1, FEZ Family zinc finger protein, [RH, Score=293, Expect=5e-94]} {Smed: dd_Smed_v6_26394_0_1, dd_Smed_v6_26394_0_1, [RH, Score=287, Expect=9e-92]} {RNA1310_14572} {RNA815_32467} |
| 46. | MligTC455_46880 | 44 | 0.91 | Mlig455_046271 | Neo: - Age: - |
IAH1 | 1.783 | - | - | - | 0.960 | - | 0.823 | Mlig455_046271 {REF} {Length: 1061} {Pfam: GDSL-like Lipase/Acylhydrolase family [PF13472.8, score=75.8]; GDSL-like Lipase/Acylhydrolase [PF00657.24, score=32.0]} {Human: ENSG00000134330, IAH1, isoamyl acetate hydrolyzing esterase 1 (putative), [Score=138, Expect=2e-39]} {Mouse: ENSMUSG00000062054, Iah1, isoamyl acetate-hydrolyzing esterase 1 homolog, [Score=121, Expect=4e-33]} {Smed: dd_Smed_v6_6241_0_1, dd_Smed_v6_6241_0_1, [Score=111, Expect=8e-30]} {RNA1310_130726} |
| 47. | MligTC455_29045 | 127 | 2.65 | Mlig455_056054 | Neo: - Age: - Region-enriched R2: 4.858/0.00652 |
FZD5 | 1.78 | - | - | - | 0.951 | - | 0.829 | Mlig455_056054 {REF} {Length: 3655} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=389.0]; Fz domain [PF01392.24, score=85.2]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [Score=554, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [Score=561, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [Score=516, Expect=5e-176]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=368, Expect=3e-120]} {Smed: dd_Smed_v6_16571_0_1, dd_Smed_v6_16571_0_1, [Score=522, Expect=7e-178]} {RNA1509_35313} {RNA1310_9623.1} {RNA815_2562.1} |
| 48. | MligTC455_39694 | 73 | 1.51 | Mlig455_021504, Mlig455_067393 | Neo: - Age: - |
1.777 | - | - | 0.960 | - | - | 0.817 | Mlig455_021504 {REF} {Length: 1105} {Pfam: Chromatin assembly factor 1 complex p150 subunit, N-terminal [PF11600.10, score=25.0]} {Smed: dd_Smed_v6_2373_0_1, dd_Smed_v6_2373_0_1, [Score=70.9, Expect=4e-13]} {RNA1509_19671} {RNA1310_1157} {RNA815_38185} Mlig455_067393 {REF} {Length: 3563} {Smed: dd_Smed_v6_2373_0_2, dd_Smed_v6_2373_0_2, [Score=112, Expect=4e-25]} {RNA1509_19671} {RNA1310_1157} {RNA815_36782} |
|
| 49. | MligTC455_42087 | 129 | 2.68 | Mlig455_028171 | Neo: - Age: - |
1.777 | - | - | - | 0.955 | - | 0.822 | Mlig455_028171 {REF} {Length: 2511} {RNA1509_40406} {RNA1310_12938} {RNA815_16887} | |
| 50. | MligTC455_19114 | 79 | 1.64 | Mlig455_045107 | Neo: - |
1.776 | - | - | - | 0.958 | - | 0.818 | Mlig455_045107 {REF} {Length: 1513} {Pfam: F5/8 type C domain [PF00754.27, score=20.0]} {RNA1509_57504} {RNA1310_27303.2} {RNA815_32964} | |
| 51. | MligTC455_31901 | 18 | 0.38 | Mlig455_022355 | Neo: - Age: - |
1.774 | - | - | - | 0.955 | - | 0.819 | Mlig455_022355 {REF} {Length: 541} {Pfam: PAN domain [PF00024.28, score=19.0]} {RNA1310_125793} {RNA815_23776.1} | |
| 52. | MligTC455_39180 | 256 | 5.34 | Mlig455_057231 | Neo: - Age: logFC(26M/2M)=-0.449 |
TCTE3 | 1.768 | - | - | - | 0.961 | - | 0.807 | Mlig455_057231 {REF} {Length: 1057} {Pfam: Tctex-1 family [PF03645.15, score=43.3]} {Human: ENSG00000275368, TCTE3, t-complex-associated-testis-expressed 3, [RH, Score=67.8, Expect=2e-13]; ENSG00000184786, TCTE3, t-complex-associated-testis-expressed 3, [RH, Score=67.8, Expect=2e-13]} {Mouse: ENSMUSG00000028523, Tctex1d1, Tctex1 domain containing 1, [Score=61.2, Expect=2e-11]; ENSMUSG00000079710, Gm3448, predicted gene 3448, [Score=59.3, Expect=1e-10]; ENSMUSG00000079707, Tcte3, t-complex-associated testis expressed 3, [Score=59.3, Expect=1e-10]; ENSMUSG00000116780, Gm3417, predicted gene 3417, [Score=58.5, Expect=2e-10]} {Smed: dd_Smed_v6_9036_0_1, dd_Smed_v6_9036_0_1, [Score=92.4, Expect=2e-23]} {RNA1509_34873, RNA1509_48552} {RNA1310_34743, RNA1509_34873, RNA1509_48552} {RNA1509_34873, RNA1509_48552, RNA815_18661} |
| 53. | MligTC455_37793 | 353 | 7.36 | Mlig455_066109, Mlig455_068663 | Neo: - Age: Up-Down-Down |
HMCN1 | 1.767 | - | - | - | 0.962 | - | 0.805 | Mlig455_066109 {REF} {Length: 7924} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=408.1]; Spondin-like TSP1 domain [PF19028.2, score=285.5]; Polycystin cation channel [PF08016.14, score=239.7]; PLAT/LH2 domain [PF01477.25, score=86.7]; Thrombospondin type 1 domain [PF19030.2, score=78.4]; Ion transport protein [PF00520.33, score=42.7]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=360, Expect=8e-99]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=363, Expect=7e-100]} {Dmel: FBgn0284221, Sema5c, Semaphorin 5c, [Score=199, Expect=5e-51]} {Celegans: WBGene00000082, adt-1, ADAMTS family; ADT-1, [RH, Score=306, Expect=4e-84]} {Smed: dd_Smed_v6_13975_0_1, dd_Smed_v6_13975_0_1, [RH, Score=944, Expect=0.0]} {RNA1509_9601} {RNA1310_488} {RNA815_1711} Mlig455_068663 {REF} {Length: 7866} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=423.7]; Spondin-like TSP1 domain [PF19028.2, score=299.7]; Thrombospondin type 1 domain [PF19030.2, score=92.3]; PLAT/LH2 domain [PF01477.25, score=23.1]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=338, Expect=1e-94]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=341, Expect=9e-96]} {Dmel: FBgn0284221, Sema5c, Semaphorin 5c, [Score=189, Expect=2e-48]} {Celegans: WBGene00000082, adt-1, ADAMTS family; ADT-1, [RH, Score=303, Expect=2e-84]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=282, Expect=3e-77]} {RNA1509_9601} {RNA1310_488} {RNA815_1711} |
| 54. | MligTC455_52974 | 208 | 4.33 | Mlig455_006731 | Neo: - Age: logFC(26M/2M)=-0.440 |
1.762 | - | - | - | 0.805 | - | 0.957 | Mlig455_006731 {REF} {Length: 2281} {TRANSSPLICED} {Pfam: Gamma-glutamyl cyclotransferase, AIG2-like [PF06094.14, score=41.4]; AIG2-like family [PF13772.8, score=36.0]} {RNA1509_12874} {RNA1310_10210.1} {RNA815_7283} | |
| 55. | MligTC455_16375 | 99 | 2.05 | Mlig455_030691 | Neo: - Age: - Region-enriched R8: 3.721/0.03273 |
RAPGEF2 | 1.755 | 0.951 | 0.804 | - | - | - | - | Mlig455_030691 {REF} {Length: 1157} {Pfam: RasGEF domain [PF00617.21, score=62.0]} {Human: ENSG00000109756, RAPGEF2, Rap guanine nucleotide exchange factor 2, [Score=78.2, Expect=2e-15]} {Mouse: ENSMUSG00000062232, Rapgef2, Rap guanine nucleotide exchange factor (GEF) 2, [Score=77.4, Expect=2e-15]} {Dmel: FBgn0085421, Epac, Exchange protein directly activated by cAMP, [Score=66.6, Expect=7e-12]} {Celegans: WBGene00004254, pxf-1, Rap guanine nucleotide exchange factor, [Score=69.3, Expect=8e-13]} {Smed: dd_Smed_v6_4950_0_2, dd_Smed_v6_4950_0_2, [Score=61.2, Expect=3e-10]} {RNA1310_33127.1} {RNA815_48107} |
| 56. | MligTC455_28202 | 337 | 7.03 | Mlig455_063876 | Neo: - Age: - Region-enriched R2: 3.393/0.00249 |
1.754 | - | - | - | 0.799 | - | 0.955 | Mlig455_063876 {REF} {Length: 9210} {Smed: dd_Smed_v6_6429_0_1, dd_Smed_v6_6429_0_1, [Score=102, Expect=3e-23]} {RNA1509_30620, RNA1509_41832, RNA1509_45836} {RNA1310_13656, RNA1509_41832, RNA1509_45836} {RNA1509_41832, RNA1509_45836, RNA815_1450.1} | |
| 57. | MligTC455_37537 | 203 | 4.23 | Mlig455_047747 | Neo: - Age: - Region-enriched R8: 3.525/0.01192 |
KCNC2 | 1.75 | 0.974 | - | - | - | 0.776 | - | Mlig455_047747 {REF} {Length: 3532} {Pfam: Ion transport protein [PF00520.33, score=105.8]; BTB/POZ domain [PF02214.24, score=56.8]; Ion channel [PF07885.18, score=52.6]} {Human: ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=216, Expect=4e-60]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=215, Expect=5e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=207, Expect=1e-56]} {Mouse: ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=218, Expect=1e-60]; ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=214, Expect=6e-60]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=230, Expect=1e-65]} {Celegans: WBGene00001202, egl-36, Potassium voltage-gated channel protein egl-36, [Score=211, Expect=5e-59]} {Smed: dd_Smed_v6_9740_0_2, dd_Smed_v6_9740_0_2, [Score=208, Expect=6e-58]} {RNA1509_26535} {RNA1310_14101} {RNA815_34993} |
| 58. | MligTC455_42088 | 72 | 1.5 | Mlig455_028244 | Neo: - Age: - |
1.742 | - | - | - | 0.963 | - | 0.779 | Mlig455_028244 {REF} {Length: 2632} {RNA1509_40406} {RNA1310_12938} {RNA815_16887} | |
| 59. | MligTC455_18499 | 24 | 0.5 | Mlig455_012628 | Neo: - Age: - |
1.738 | - | - | - | 0.954 | - | 0.784 | Mlig455_012628 {REF} {Length: 1340} {Smed: dd_Smed_v6_500_0_1, dd_Smed_v6_500_0_1, [Score=60.5, Expect=1e-10]} {RNA1310_107419} {RNA815_46554} | |
| 60. | MligTC455_23309 | 257 | 5.35 | Mlig455_013628 | Neo: - Age: Up-Down-Up |
1.735 | 0.972 | - | - | - | - | 0.763 | Mlig455_013628 {REF} {Length: 1039} {RNA1509_48616} {RNA1310_6959, RNA1509_48616} {RNA1509_48616, RNA815_10949} | |
| 61. | MligTC455_42351 | 126 | 2.62 | Mlig455_014089 | Neo: - Age: Up-Down-Down |
BMP1 | 1.734 | - | - | - | 0.959 | - | 0.775 | Mlig455_014089 {REF} {Length: 6334} {Pfam: CUB domain [PF00431.22, score=147.3]} {Human: ENSG00000168487, BMP1, bone morphogenetic protein 1, [Score=107, Expect=7e-23]} {Mouse: ENSMUSG00000053626, Tll1, tolloid-like, [Score=97.8, Expect=3e-20]; ENSMUSG00000025013, Tll2, tolloid-like 2, [Score=95.9, Expect=1e-19]} {Dmel: FBgn0261262, CG42613, [Score=274, Expect=4e-77]} {Celegans: WBGene00002977, lev-10, LEV-10B, [Score=235, Expect=6e-65]} {Smed: dd_Smed_v6_11447_0_1, dd_Smed_v6_11447_0_1, [Score=401, Expect=2e-123]} {RNA1509_7178} {RNA1310_25466} {RNA815_477.1} |
| 62. | MligTC455_38042 | 175 | 3.64 | Mlig455_032349 | Neo: - |
ANKRD28 | 1.732 | - | - | - | 0.782 | - | 0.950 | Mlig455_032349 {REF} {Length: 2134} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=114.5]; Ankyrin repeats (many copies) [PF13637.8, score=79.6]; Ankyrin repeats (many copies) [PF13857.8, score=77.6]; Ankyrin repeat [PF00023.32, score=64.8]; Ankyrin repeat [PF13606.8, score=61.6]} {Human: ENSG00000206560, ANKRD28, ankyrin repeat domain 28, [Score=67.4, Expect=2e-11]; ENSG00000203780, FANK1, fibronectin type III and ankyrin repeat domains 1, [Score=65.9, Expect=2e-11]} {Mouse: ENSMUSG00000014496, Ankrd28, ankyrin repeat domain 28, [Score=67.4, Expect=1e-11]} {Dmel: FBgn0039590, CG10011, [Score=61.2, Expect=9e-10]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=50.8, Expect=1e-06]} {Smed: dd_Smed_v6_2072_0_29, dd_Smed_v6_2072_0_29, [Score=58.9, Expect=2e-09]} {RNA1509_50870} {RNA1310_30962} {RNA815_23812} |
| 63. | MligTC455_46395 | 870 | 18.13 | Mlig455_069471 | Neo: - Age: logFC(26M/2M)=0.458 |
PKD2 | 1.732 | - | - | - | 0.956 | - | 0.776 | Mlig455_069471 {REF} {Length: 3122} {TRANSSPLICED} {Pfam: Polycystin cation channel [PF08016.14, score=487.8]; Ion transport protein [PF00520.33, score=93.3]; EF hand [PF00036.34, score=32.7]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=21.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=753, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=750, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=323, Expect=1e-96]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=387, Expect=8e-123]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=769, Expect=0.0]} {RNA1509_13522} {RNA1310_21296.2} {RNA815_3158.1} |
| 64. | MligTC455_24861 | 117 | 2.44 | Mlig455_019572 | Neo: - Age: - Region-enriched R8: 4.245/0.00630 |
FREM1 | 1.725 | 0.969 | - | - | 0.756 | - | - | Mlig455_019572 {REF} {Length: 8695} {Pfam: Cadherin-like [PF16184.7, score=328.8]; Frem protein N-terminal domain [PF19309.1, score=92.3]; Lectin C-type domain [PF00059.23, score=31.6]} {Human: ENSG00000164946, FREM1, FRAS1 related extracellular matrix 1, [RH, Score=370, Expect=2e-102]} {Mouse: ENSMUSG00000059049, Frem1, Fras1 related extracellular matrix protein 1, [RH, Score=381, Expect=3e-106]} {Smed: dd_Smed_v6_5187_0_1, dd_Smed_v6_5187_0_1, [RH, Score=508, Expect=4e-147]} {RNA1509_8234} {RNA1310_595.1} {RNA815_322} |
| 65. | MligTC455_18899 | 25 | 0.51 | Mlig455_022106 | Neo: - Age: - |
1.724 | - | - | - | 0.957 | - | 0.767 | Mlig455_022106 {REF} {Length: 1792} {Pfam: F5/8 type C domain [PF00754.27, score=28.8]} {Smed: dd_Smed_v6_71482_0_1, dd_Smed_v6_71482_0_1, [Score=62.0, Expect=1e-11]} {RNA1310_41523} {RNA815_37841} | |
| 66. | MligTC455_21809 | 208 | 4.34 | Mlig455_000032, Mlig455_063708 | Neo: - Age: Down-Up-Up |
TRIM71 | 1.723 | - | - | 0.772 | - | - | 0.951 | Mlig455_000032 {REF} {Length: 3376} {TRANSSPLICED} {Pfam: B-box zinc finger [PF00643.26, score=29.0]; NHL repeat [PF01436.23, score=23.8]; 6-bladed beta-propeller [PF17170.6, score=19.1]} {Human: ENSG00000206557, TRIM71, tripartite motif containing 71, [Score=53.9, Expect=6e-07]} {Mouse: ENSMUSG00000079259, Trim71, tripartite motif-containing 71, [Score=50.8, Expect=4e-06]} {Dmel: FBgn0265356, tn, thin, [Score=54.3, Expect=2e-07]} {Celegans: WBGene00003597, nhl-1, RING finger protein nhl-1, [Score=57.8, Expect=1e-08]} {RNA1509_60167} {RNA1310_24197} {RNA815_26869} Mlig455_063708 {REF} {Length: 3375} {TRANSSPLICED} {Pfam: B-box zinc finger [PF00643.26, score=29.0]; NHL repeat [PF01436.23, score=23.8]; 6-bladed beta-propeller [PF17170.6, score=19.1]} {Human: ENSG00000206557, TRIM71, tripartite motif containing 71, [Score=53.9, Expect=6e-07]} {Mouse: ENSMUSG00000079259, Trim71, tripartite motif-containing 71, [Score=50.8, Expect=4e-06]} {Dmel: FBgn0265356, tn, thin, [Score=54.3, Expect=2e-07]} {Celegans: WBGene00003597, nhl-1, RING finger protein nhl-1, [Score=57.8, Expect=1e-08]} {RNA1509_60167} {RNA1310_24197, RNA1509_60167} {RNA1509_60167, RNA815_26869} |
| 67. | MligTC455_26248 | 162 | 3.38 | Mlig455_052600, Mlig455_052650 | Neo: - Age: - |
1.722 | - | - | - | - | 0.951 | 0.771 | Mlig455_052600 {REF} {Length: 3376} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=155.1]} {Smed: dd_Smed_v6_9633_0_1, dd_Smed_v6_9633_0_1, [Score=67.0, Expect=1e-11]} {RNA1509_10005} {RNA1310_10838.1} {RNA815_11723} Mlig455_052650 {REF} {Length: 3364} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=155.1]} {Smed: dd_Smed_v6_9633_0_1, dd_Smed_v6_9633_0_1, [Score=67.0, Expect=1e-11]} {RNA1509_10005} {RNA1310_10838.1} {RNA815_11723} |
|
| 68. | MligTC455_50750 | 137 | 2.86 | Mlig455_004587 | Neo: - Age: - |
GNB5 | 1.72 | - | - | 0.951 | - | - | 0.769 | Mlig455_004587 {REF} {Length: 6245} {Pfam: WD domain, G-beta repeat [PF00400.34, score=96.6]; Anaphase-promoting complex subunit 4 WD40 domain [PF12894.9, score=48.4]; Eukaryotic translation initiation factor eIF2A [PF08662.13, score=26.3]; WD40-like domain [PF17005.7, score=24.1]} {Human: ENSG00000069966, GNB5, G protein subunit beta 5, [Score=411, Expect=2e-144]} {Mouse: ENSMUSG00000032192, Gnb5, guanine nucleotide binding protein (G protein), beta 5, [Score=412, Expect=9e-145]} {Dmel: FBgn0030011, Gbeta5, [Score=430, Expect=4e-152]} {Celegans: WBGene00001680, gpb-2, Guanine nucleotide-binding protein subunit beta-2, [Score=402, Expect=6e-141]} {Smed: dd_Smed_v6_10481_0_1, dd_Smed_v6_10481_0_1, [Score=476, Expect=9e-171]} {RNA1509_51468} {RNA1310_13844.1} {RNA815_14582} |
| 69. | MligTC455_29030 | 141 | 2.93 | Mlig455_061986 | Neo: - Age: logFC(26M/2M)=-0.349 Region-enriched R2: 5.117/0.03372 |
FZD5 | 1.709 | - | - | - | 0.956 | - | 0.753 | Mlig455_061986 {REF} {Length: 3701} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=386.1]; Fz domain [PF01392.24, score=95.9]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [Score=582, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [RH, Score=586, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [Score=545, Expect=0.0]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=388, Expect=7e-127]} {Smed: dd_Smed_v6_16571_0_1, dd_Smed_v6_16571_0_1, [RH, Score=556, Expect=0.0]} {RNA1509_35313} {RNA1310_9623.1} {RNA815_2562.1} |
| 70. | MligTC455_35942 | 1134 | 23.63 | Mlig455_048067 | Neo: - Age: logFC(26M/2M)=-0.435 |
DCDC2C | 1.707 | - | - | - | 0.748 | - | 0.959 | Mlig455_048067 {REF} {Length: 3258} {Pfam: Doublecortin [PF03607.19, score=93.4]} {Human: ENSG00000214866, DCDC2C, doublecortin domain containing 2C, [RH, Score=100, Expect=7e-23]; ENSG00000146038, DCDC2, doublecortin domain containing 2, [RH, Score=100, Expect=3e-22]} {Mouse: ENSMUSG00000035910, Dcdc2a, doublecortin domain containing 2a, [RH, Score=105, Expect=2e-24]} {Celegans: WBGene00007374, C06C3.3, [RH, Score=52.4, Expect=4e-07]} {Smed: dd_Smed_v6_20159_0_1, dd_Smed_v6_20159_0_1, [RH, Score=187, Expect=9e-55]} {RNA1509_40680} {RNA1310_11042} {RNA815_6202} |
| 71. | MligTC455_35435 | 632 | 13.16 | Mlig455_067119 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.896 Region-enriched R2: 1.234/0.03490 Regeneration-downregulated R5: -1.845 Regeneration-depleted R5: -1.845 |
1.699 | - | - | - | 0.722 | - | 0.977 | Mlig455_067119 {REF} {Length: 1795} {RNA1509_9585} {RNA1310_17157, RNA1509_9585} {RNA1509_9585, RNA815_623.1} | |
| 72. | MligTC455_27079 | 28 | 0.58 | Mlig455_022102 | Neo: - Age: - |
1.696 | - | - | 0.994 | - | - | 0.702 | Mlig455_022102 {REF} {Length: 1305} {RNA1509_44223} {RNA1310_77029} {RNA815_64986} | |
| 73. | MligTC455_31916 | 78 | 1.63 | Mlig455_067080 | Neo: - Age: - |
1.692 | - | - | - | 0.728 | - | 0.964 | Mlig455_067080 {REF} {Length: 1168} {NoTransDecoderORF} {RNA1509_48060} {RNA1310_6149} {RNA815_1772.1} | |
| 74. | MligTC455_04662 | 2358 | 49.13 | Mlig455_056586, Mlig455_056607 | Neo: - Age: - |
ROPN1L | 1.691 | - | - | - | 0.741 | - | 0.950 | Mlig455_056586 {REF} {Length: 873} {TRANSSPLICED} {Human: ENSG00000145491, ROPN1L, rhophilin associated tail protein 1 like, [RH, Score=207, Expect=5e-67]} {Mouse: ENSMUSG00000022236, Ropn1l, ropporin 1-like, [RH, Score=207, Expect=4e-67]} {Smed: dd_Smed_v6_4888_0_1, dd_Smed_v6_4888_0_1, [RH, Score=278, Expect=9e-96]} {RNA1509_37498} {RNA1310_39913} {RNA815_19368} Mlig455_056607 {REF} {Length: 872} {TRANSSPLICED} {Human: ENSG00000145491, ROPN1L, rhophilin associated tail protein 1 like, [RH, Score=207, Expect=5e-67]} {Mouse: ENSMUSG00000022236, Ropn1l, ropporin 1-like, [RH, Score=207, Expect=4e-67]} {Smed: dd_Smed_v6_4888_0_1, dd_Smed_v6_4888_0_1, [RH, Score=278, Expect=9e-96]} {RNA1509_37498, RNA1509_42995} {RNA1310_39913, RNA1509_37498, RNA1509_42995} {RNA1509_37498, RNA1509_42995, RNA815_19368} |
| 75. | MligTC455_49883 | 494 | 10.3 | Mlig455_048284 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.589 Region-enriched R2: 2.307/0.03081 |
ENO4 | 1.689 | - | - | 0.719 | - | - | 0.970 | Mlig455_048284 {REF} {Length: 2744} {Pfam: Enolase, C-terminal TIM barrel domain [PF00113.24, score=105.9]; Enolase, N-terminal domain [PF03952.18, score=35.3]} {Human: ENSG00000188316, ENO4, enolase 4, [RH, Score=218, Expect=9e-62]} {Mouse: ENSMUSG00000048029, Eno4, enolase 4, [RH, Score=204, Expect=3e-57]} {Dmel: FBgn0000579, Eno, Enolase, [Score=86.3, Expect=1e-17]} {Celegans: WBGene00011884, enol-1, Enolase, [Score=96.7, Expect=4e-21]} {Smed: dd_Smed_v6_12607_0_1, dd_Smed_v6_12607_0_1, [RH, Score=185, Expect=5e-51]} {RNA1509_28987, RNA1509_47129} {RNA1310_7158.1, RNA1509_47129} {RNA1509_47129, RNA815_8709} |
| 76. | MligTC455_39874 | 143 | 2.98 | Mlig455_049425 | Neo: - Age: - |
PKDCC | 1.686 | - | - | - | 0.955 | - | 0.731 | Mlig455_049425 {REF} {Length: 3789} {Pfam: Protein-kinase domain of FAM69 [PF12260.10, score=30.6]; Protein kinase domain [PF00069.27, score=21.0]} {Human: ENSG00000162878, PKDCC, protein kinase domain containing, cytoplasmic, [RH, Score=192, Expect=4e-55]} {Mouse: ENSMUSG00000024247, Pkdcc, protein kinase domain containing, cytoplasmic, [RH, Score=180, Expect=9e-51]} {RNA1310_12305} {RNA815_19030.1} |
| 77. | MligTC455_41738 | 22 | 0.45 | Mlig455_049770 | Neo: - Age: - |
PCIF1 | 1.686 | - | - | 0.717 | - | 0.969 | - | Mlig455_049770 {REF} {Length: 2631} {Pfam: Phosphorylated CTD interacting factor 1 WW domain [PF12237.10, score=100.0]} {Human: ENSG00000100982, PCIF1, PDX1 C-terminal inhibiting factor 1, [Score=63.2, Expect=3e-10]} {Mouse: ENSMUSG00000039849, Pcif1, PDX1 C-terminal inhibiting factor 1, [Score=62.4, Expect=4e-10]} {Smed: dd_Smed_v6_4647_0_1, dd_Smed_v6_4647_0_1, [Score=162, Expect=8e-46]} {RNA1310_17554.1} {RNA815_8653} |
| 78. | MligTC455_18479 | 293 | 6.11 | Mlig455_029348 | Neo: - Age: - Region-enriched R2: 2.256/0.00988 |
1.683 | - | - | - | 0.709 | - | 0.974 | Mlig455_029348 {REF} {Length: 2771} {Pfam: Leucine Rich repeat [PF13516.8, score=43.0]} {Mouse: ENSMUSG00000099564, Gm28729, predicted gene 28729, [RH, Score=125, Expect=4e-31]} {Smed: dd_Smed_v6_16437_0_1, dd_Smed_v6_16437_0_1, [RH, Score=268, Expect=2e-84]} {RNA1509_18255, RNA1509_55057} {RNA1310_16954, RNA1509_18255, RNA1509_55057} {RNA1509_18255, RNA1509_55057, RNA815_6360} | |
| 79. | MligTC455_38774 | 13 | 0.28 | Mlig455_056173, Mlig455_058730 | Neo: - Age: - |
GALR2 | 1.683 | - | - | 0.717 | - | 0.966 | - | Mlig455_056173 {REF} {Length: 2381} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=152.4]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=35.1]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=20.1]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=50.4, Expect=4e-06]; ENSG00000180269, GPR139, G protein-coupled receptor 139, [Score=48.1, Expect=1e-05]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=53.5, Expect=2e-07]} {Dmel: FBgn0033579, CG13229, [Score=179, Expect=1e-51]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=218, Expect=1e-66]} {Smed: dd_Smed_v6_15468_0_1, dd_Smed_v6_15468_0_1, [Score=248, Expect=2e-78]} {RNA1310_25407.1} {RNA815_38269} Mlig455_058730 {REF} {Length: 2507} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=123.1]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=31.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.3]} {Dmel: FBgn0033579, CG13229, [Score=139, Expect=6e-37]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=175, Expect=5e-50]} {Smed: dd_Smed_v6_15468_0_2, dd_Smed_v6_15468_0_2, [Score=209, Expect=2e-63]} {RNA1310_25407.1} {RNA815_42074} |
| 80. | MligTC455_18322 | 82 | 1.71 | Mlig455_021228 | Neo: - |
1.679 | - | - | - | 0.952 | - | 0.727 | Mlig455_021228 {REF} {Length: 3954} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=26.3]} {Smed: dd_Smed_v6_11972_0_1, dd_Smed_v6_11972_0_1, [RH, Score=229, Expect=2e-64]} {RNA1509_9124} {RNA1310_5268.1, RNA1509_9124} {RNA1509_9124, RNA815_1717.1} | |
| 81. | MligTC455_23227 | 61 | 1.28 | Mlig455_001505 | Neo: - Age: - |
EPHA7 | 1.676 | 0.961 | - | - | - | 0.715 | - | Mlig455_001505 {REF} {Length: 4755} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=295.0]; Protein kinase domain [PF00069.27, score=136.9]; Ephrin receptor ligand binding domain [PF01404.21, score=117.2]; Fibronectin type III domain [PF00041.23, score=79.8]; Ephrin type-A receptor 2 transmembrane domain [PF14575.8, score=70.8]; SAM domain (Sterile alpha motif) [PF07647.19, score=58.4]; SAM domain (Sterile alpha motif) [PF00536.32, score=57.4]; Tyrosine-protein kinase ephrin type A/B receptor-like [PF07699.15, score=26.4]; ABC1 atypical kinase-like domain [PF03109.18, score=22.2]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=19.5]} {Human: ENSG00000135333, EPHA7, EPH receptor A7, [RH, Score=716, Expect=0.0]; ENSG00000145242, EPHA5, EPH receptor A5, [RH, Score=696, Expect=0.0]; ENSG00000116106, EPHA4, EPH receptor A4, [RH, Score=694, Expect=0.0]} {Mouse: ENSMUSG00000028289, Epha7, Eph receptor A7, [RH, Score=716, Expect=0.0]; ENSMUSG00000026235, Epha4, Eph receptor A4, [RH, Score=697, Expect=0.0]; ENSMUSG00000029245, Epha5, Eph receptor A5, [RH, Score=692, Expect=0.0]} {Dmel: FBgn0025936, Eph, Eph receptor tyrosine kinase, [RH, Score=676, Expect=0.0]} {Celegans: WBGene00006868, vab-1, Ephrin receptor 1, [RH, Score=485, Expect=6e-153]} {Smed: dd_Smed_v6_16928_0_1, dd_Smed_v6_16928_0_1, [RH, Score=579, Expect=0.0]} {RNA1509_51951} {RNA1310_5149.1} {RNA815_23934} |
| 82. | MligTC455_40228 | 146 | 3.03 | Mlig455_010654, Mlig455_010753 | Neo: - Age: logFC(26M/2M)=0.372 Region-enriched R2: 5.064/0.02014 |
KY | 1.672 | - | - | - | 0.961 | - | 0.711 | Mlig455_010654 {REF} {Length: 3057} {Human: ENSG00000174611, KY, kyphoscoliosis peptidase, [Score=103, Expect=6e-22]} {Mouse: ENSMUSG00000035606, Ky, kyphoscoliosis peptidase, [Score=113, Expect=2e-25]} {Dmel: FBgn0050147, Hil, Hillarin, [Score=373, Expect=6e-115]} {Celegans: WBGene00003089, ltd-1, Lim and Transglutaminase Domain; Lim and transglutaminase domain protein, [RH, Score=347, Expect=3e-106]} {Smed: dd_Smed_v6_1846_0_1, dd_Smed_v6_1846_0_1, [Score=207, Expect=1e-55]} {RNA1509_35609} {RNA1310_6947.1} {RNA815_20684} Mlig455_010753 {REF} {Length: 3328} {Pfam: LIM domain [PF00412.24, score=33.6]} {Human: ENSG00000174611, KY, kyphoscoliosis peptidase, [Score=104, Expect=3e-22]} {Mouse: ENSMUSG00000035606, Ky, kyphoscoliosis peptidase, [Score=114, Expect=2e-25]} {Dmel: FBgn0050147, Hil, Hillarin, [Score=376, Expect=1e-115]} {Celegans: WBGene00003089, ltd-1, Lim and Transglutaminase Domain; Lim and transglutaminase domain protein, [RH, Score=353, Expect=4e-108]} {Smed: dd_Smed_v6_1846_0_1, dd_Smed_v6_1846_0_1, [Score=207, Expect=2e-55]} {RNA1509_35609} {RNA1310_6947.1, RNA1509_35609} {RNA1509_35609, RNA815_20684} |
| 83. | MligTC455_13095 | 40 | 0.82 | Mlig455_036239 | Neo: - Age: - |
1.666 | - | - | 0.706 | 0.960 | - | - | Mlig455_036239 {REF} {Length: 2786} {RNA1509_41201} {RNA1310_51044} {RNA815_51130} | |
| 84. | MligTC455_37792 | 210 | 4.38 | Mlig455_024774 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.926 Region-enriched R2: 6.055/0.00271 |
PKD1L2 | 1.665 | - | - | - | 0.962 | - | 0.703 | Mlig455_024774 {REF} {Length: 6374} {Pfam: Polycystin cation channel [PF08016.14, score=224.6]; PLAT/LH2 domain [PF01477.25, score=66.8]; Ion transport protein [PF00520.33, score=30.8]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [Score=179, Expect=9e-45]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=187, Expect=3e-47]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=109, Expect=1e-23]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=187, Expect=2e-47]} {Smed: dd_Smed_v6_13975_0_1, dd_Smed_v6_13975_0_1, [Score=902, Expect=0.0]} {RNA1509_46134} {RNA1310_488} {RNA815_1711} |
| 85. | MligTC455_08853 | 22 | 0.45 | Mlig455_068998 | Neo: - Age: - |
1.658 | - | - | - | 0.951 | - | 0.707 | Mlig455_068998 {REF} {Length: 1981} {Pfam: Glycine rich protein [PF12810.9, score=35.1]} {RNA1310_75162} {RNA815_38988} | |
| 86. | MligTC455_15580 | 8 | 0.18 | Mlig455_016128 | Neo: - Age: - |
0.998 | - | - | 0.998 | - | - | - | Mlig455_016128 {REF} {Length: 1492} | |
| 87. | MligTC455_52767 | 21 | 0.43 | Mlig455_039993 | Neo: - Age: - Region-enriched R2: 6.584/0.03176 |
0.998 | - | - | 0.998 | - | - | - | Mlig455_039993 {REF} {Length: 2109} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=23.3]} {RNA1310_67588} {RNA815_46201} | |
| 88. | MligTC455_55942 | 14 | 0.3 | Mlig455_007077 | Neo: - Age: - Region-enriched R4: 2.980/0.03313 |
0.998 | - | - | 0.998 | - | - | - | Mlig455_007077 {REF} {Length: 422} {NoTransDecoderORF} | |
| 89. | MligTC455_39772 | 149 | 3.1 | Mlig455_021243 | Neo: - Age: - Region-enriched R7: 3.021/0.00442 |
GEM | 0.996 | - | - | 0.996 | - | - | - | Mlig455_021243 {REF} {Length: 3783} {Pfam: Ras family [PF00071.24, score=77.9]; RsgA GTPase [PF03193.18, score=24.7]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=21.0]} {Human: ENSG00000164949, GEM, GTP binding protein overexpressed in skeletal muscle, [Score=97.4, Expect=8e-22]} {Mouse: ENSMUSG00000028214, Gem, GTP binding protein (gene overexpressed in skeletal muscle), [Score=97.4, Expect=5e-22]} {Dmel: FBgn0264753, Rgk1, Rad, Gem/Kir family member 1, [RH, Score=150, Expect=9e-38]} {Celegans: WBGene00013124, Y52B11A.4, [RH, Score=80.9, Expect=5e-16]} {Smed: dd_Smed_v6_11010_0_1, dd_Smed_v6_11010_0_1, [Score=163, Expect=9e-45]} {RNA1310_32533.1} {RNA815_17720} |
| 90. | MligTC455_52652 | 6 | 0.13 | Mlig455_034341 | Neo: - Age: - |
P2RX4 | 0.995 | - | - | 0.995 | - | - | - | Mlig455_034341 {REF} {Length: 2208} {Pfam: ATP P2X receptor [PF00864.21, score=143.8]} {Human: ENSG00000135124, P2RX4, purinergic receptor P2X 4, [Score=121, Expect=3e-31]} {Mouse: ENSMUSG00000029470, P2rx4, purinergic receptor P2X, ligand-gated ion channel 4, [Score=105, Expect=1e-25]; ENSMUSG00000029468, P2rx7, purinergic receptor P2X, ligand-gated ion channel, 7, [Score=104, Expect=1e-24]; ENSMUSG00000005950, P2rx5, purinergic receptor P2X, ligand-gated ion channel, 5, [Score=102, Expect=4e-24]; ENSMUSG00000029503, P2rx2, purinergic receptor P2X, ligand-gated ion channel, 2, [Score=101, Expect=7e-24]} {Smed: dd_Smed_v6_10968_0_1, dd_Smed_v6_10968_0_1, [Score=161, Expect=1e-45]} {RNA1509_56886} {RNA1310_41878} {RNA815_21866} |
| 91. | MligTC455_52653 | 6 | 0.13 | Mlig455_034395 | Neo: - Age: - |
P2RX4 | 0.99 | - | - | 0.990 | - | - | - | Mlig455_034395 {REF} {Length: 2942} {Pfam: ATP P2X receptor [PF00864.21, score=433.9]} {Human: ENSG00000135124, P2RX4, purinergic receptor P2X 4, [Score=331, Expect=2e-108]} {Mouse: ENSMUSG00000029470, P2rx4, purinergic receptor P2X, ligand-gated ion channel 4, [Score=310, Expect=2e-100]} {Smed: dd_Smed_v6_10968_0_1, dd_Smed_v6_10968_0_1, [RH, Score=417, Expect=3e-141]} {RNA1310_29566.1} {RNA815_49663} |
| 92. | MligTC455_18284 | 58 | 1.21 | Mlig455_020141 | Neo: - Age: logFC(26M/2M)=0.808 |
XPO1 | 0.989 | - | - | 0.989 | - | - | - | Mlig455_020141 {REF} {Length: 3553} {TRANSSPLICED} {Pfam: CRM1 C terminal [PF08767.13, score=277.8]; CRM1 / Exportin repeat 2 [PF18784.3, score=119.1]; CRM1 / Exportin repeat 3 [PF18787.3, score=97.0]; Exportin 1-like protein [PF08389.14, score=84.0]; Chromosome region maintenance or exportin repeat [PF18777.3, score=62.5]; Importin-beta N-terminal domain [PF03810.21, score=50.9]; Down-regulated in metastasis [PF07539.14, score=22.4]} {Human: ENSG00000082898, XPO1, exportin 1, [Score=1325, Expect=0.0]} {Mouse: ENSMUSG00000020290, Xpo1, exportin 1, [Score=1321, Expect=0.0]} {Dmel: FBgn0020497, emb, embargoed, [Score=1167, Expect=0.0]} {Celegans: WBGene00002078, xpo-1, EXPOrtin (Nuclear export receptor), [Score=922, Expect=0.0]} {Smed: dd_Smed_v6_3264_0_1, dd_Smed_v6_3264_0_1, [Score=1295, Expect=0.0]} {RNA1509_1988} {RNA1310_2868} {RNA815_846} |
| 93. | MligTC455_06139 | 5 | 0.1 | Mlig455_060149 | Neo: - Age: - |
0.988 | - | - | 0.988 | - | - | - | Mlig455_060149 {REF} {Length: 980} {RNA1310_23886.1} {RNA815_8813.1} | |
| 94. | MligTC455_43131 | 121 | 2.51 | Mlig455_042022 | Neo: - Age: Down-Down-Up |
ANK1 | 0.986 | - | - | 0.986 | - | - | - | Mlig455_042022 {REF} {Length: 2609} {TRANSSPLICED} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=59.5]; Ankyrin repeats (many copies) [PF13857.8, score=57.9]; Ankyrin repeats (many copies) [PF13637.8, score=55.3]; Ankyrin repeat [PF13606.8, score=44.4]; Ankyrin repeat [PF00023.32, score=40.3]; SOCS box [PF07525.18, score=31.4]} {Human: ENSG00000029534, ANK1, ankyrin 1, [Score=67.0, Expect=2e-11]; ENSG00000145362, ANK2, ankyrin 2, [Score=66.2, Expect=3e-11]; ENSG00000151150, ANK3, ankyrin 3, [Score=64.7, Expect=1e-10]} {Mouse: ENSMUSG00000031543, Ank1, ankyrin 1, erythroid, [Score=67.4, Expect=1e-11]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=64.7, Expect=1e-10]} {Dmel: FBgn0016920, nompC, no mechanoreceptor potential C, [Score=64.3, Expect=7e-11]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=57.8, Expect=6e-09]} {Smed: dd_Smed_v6_10835_0_1, dd_Smed_v6_10835_0_1, [Score=61.2, Expect=4e-10]} {RNA1509_37297} {RNA1310_14378} {RNA815_6651} |
| 95. | MligTC455_31284 | 77 | 1.6 | Mlig455_013774 | Neo: - Age: Down-Up-Down Region-enriched R4: 3.581/0.04056 |
DECR2 | 0.985 | - | - | 0.985 | - | - | - | Mlig455_013774 {REF} {Length: 2894} {TRANSSPLICED} {Pfam: short chain dehydrogenase [PF00106.27, score=135.8]; Enoyl-(Acyl carrier protein) reductase [PF13561.8, score=111.7]; KR domain [PF08659.12, score=35.6]} {Human: ENSG00000242612, DECR2, 2,4-dienoyl-CoA reductase 2, [RH, Score=186, Expect=3e-57]; ENSG00000274296, DECR2, 2,4-dienoyl-CoA reductase 2, [RH, Score=186, Expect=3e-57]} {Mouse: ENSMUSG00000036775, Decr2, 2-4-dienoyl-Coenzyme A reductase 2, peroxisomal, [RH, Score=167, Expect=3e-50]} {Dmel: FBgn0021765, scu, scully, [Score=70.5, Expect=5e-14]} {Celegans: WBGene00011467, decr-1.3, Probable 2,4-dienoyl-CoA reductase 3, [Score=89.7, Expect=1e-20]} {Smed: dd_Smed_v6_7587_0_1, dd_Smed_v6_7587_0_1, [Score=67.4, Expect=4e-13]} {RNA1509_11650, RNA1509_18555} {RNA1310_39242, RNA1509_11650} {RNA1509_11650, RNA815_24157} |
| 96. | MligTC455_28286 | 49 | 1.01 | Mlig455_023537 | Neo: - Age: - |
0.979 | - | - | 0.979 | - | - | - | Mlig455_023537 {REF} {Length: 2542} {NoTransDecoderORF} {RNA1509_35077} {RNA1310_17510.1} {RNA815_9674} | |
| 97. | MligTC455_18655 | 16 | 0.34 | Mlig455_032705 | Neo: - Age: logFC(26M/2M)=0.485 |
PPME1 | 0.978 | - | - | - | - | 0.978 | - | Mlig455_032705 {REF} {Length: 3425} {TRANSSPLICED} {Pfam: Alpha/beta hydrolase family [PF12697.9, score=77.7]; alpha/beta hydrolase fold [PF00561.22, score=33.1]; Serine aminopeptidase, S33 [PF12146.10, score=30.1]; SOCE-associated regulatory factor of calcium homoeostasis [PF06682.14, score=20.0]} {Human: ENSG00000214517, PPME1, protein phosphatase methylesterase 1, [RH, Score=275, Expect=4e-83]} {Mouse: ENSMUSG00000030718, Ppme1, protein phosphatase methylesterase 1, [Score=161, Expect=1e-42]} {Dmel: FBgn0035951, CG5068, [RH, Score=263, Expect=3e-79]} {Celegans: WBGene00007188, B0464.9, Probable protein phosphatase methylesterase 1, [RH, Score=152, Expect=6e-40]} {Smed: dd_Smed_v6_5813_0_1, dd_Smed_v6_5813_0_1, [RH, Score=293, Expect=2e-90]} {RNA1509_18678} {RNA1310_14476} {RNA815_3742.1} |
| 98. | MligTC455_14869 | 56 | 1.17 | Mlig455_041087 | Neo: - Age: - |
0.977 | 0.977 | - | - | - | - | - | Mlig455_041087 {REF} {Length: 1408} {RNA1310_35281} {RNA815_59011} | |
| 99. | MligTC455_23308 | 249 | 5.18 | Mlig455_013575 | Neo: - Age: Up-Down-Down |
0.977 | 0.977 | - | - | - | - | - | Mlig455_013575 {REF} {Length: 832} {RNA1509_48616} {RNA1310_6959} {RNA815_10949} | |
| 100. | MligTC455_11619 | 48 | 1 | Mlig455_015930, Mlig455_059692 | Neo: - Age: - |
CPNE3 | 0.976 | - | - | 0.976 | - | - | - | Mlig455_015930 {REF} {Length: 2409} {Pfam: C2 domain [PF00168.32, score=33.7]} {Human: ENSG00000085719, CPNE3, copine 3, [Score=87.4, Expect=6e-19]} {Mouse: ENSMUSG00000028228, Cpne3, copine III, [Score=85.5, Expect=2e-18]; ENSMUSG00000074643, Cpne1, copine I, [Score=81.6, Expect=2e-17]} {Celegans: WBGene00012128, nra-1, Nicotinic receptor-associated protein 1, [Score=57.0, Expect=5e-09]} {Smed: dd_Smed_v6_2149_0_4, dd_Smed_v6_2149_0_4, [Score=75.1, Expect=3e-15]} {RNA1310_39685} {RNA815_22508} Mlig455_059692 {REF} {Length: 2378} {Pfam: C2 domain [PF00168.32, score=33.7]} {Human: ENSG00000085719, CPNE3, copine 3, [Score=87.8, Expect=4e-19]} {Mouse: ENSMUSG00000028228, Cpne3, copine III, [Score=85.9, Expect=1e-18]} {Celegans: WBGene00012128, nra-1, Nicotinic receptor-associated protein 1, [Score=55.5, Expect=1e-08]} {Smed: dd_Smed_v6_2149_0_4, dd_Smed_v6_2149_0_4, [Score=75.1, Expect=3e-15]} {RNA1310_39685} {RNA815_22508} |
There are 82 more genes with r >= 0.95